Clinical Trials Browser

Completed × talazoparib × CNS × Clear all

NCT04740190 2025-06-11

TAC-GReD

Phase 2 Completed

Glioblastoma, Glioma

NCT02116777 2021-03-26

Talazoparib and Temozolomide in Treating Younger Patients With Refractory or Recurrent Malignancies

Phase 1/2 Completed

40 enrolled 32 charts

Central Nervous System Neoplasms, Neuroectodermal Tumors, Primitive, Peripheral